|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Cuba
Espicom Business Intelligence Ltd, Jan 2010, Pages: 54
This in-depth pharmaceutical market report is ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Executive Summary
Scarce microeconomic data make economic projections difficult. According to the Economist Intelligence Unit (EIU), the government is expected to tackle the economic slowdown and improve relations with the USA, if that is possible. Bilateral relations between the USA and Cuba have increased since Barack Obama took office as US President in January 2009. Obama has moved to ease travel restrictions and remittances to Cuba but not the trade embargo. In September 2009, the USA opted to extend the embargo for another year. In recent months, Spain has also also tried to improve EU-Cuban relations. GDP growth will be moderate between 2010 and 2015, but is expected to increase in the long term.
Cuba has a relatively strong domestic pharmaceutical and biotechnological industry, which responds to the needs of the population and export opportunities. Domestic production accounts for between 80% and 90% of the market, the remainder being imports. Cuba develops leading vaccines and drugs to treat HIV/AIDS, circulatory diseases and cancer. These are of interest particularly to many developing countries in search of cheap generics or technology transfer. Cuba also undertakes a high number of clinical trials; 24 anti-cancer biotech products were being trialled in June 2009.
QUIMEFA’s enterprise production programme 2007-2012 includes 73 products of which 31 substitute imports. Domestic production concentrates on generic pharmaceuticals and vaccines. Production is GMP compliant, and selected pharmaceuticals meet bioequivalence standards. Economically, medical and pharmaceutical services remain priority export sectors. Three new technologically advanced plants opened in 2008, producing ampoules, injectables and non-freon gas aerosols with other new plants planned for unguents & creams, injectable solutions and serums.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data,
Customers who bought this item also bought
The Pharmaceutical Market: USA
The Medical Device Market: Cuba
The Pharmaceutical Market: Ireland
The Pharmaceutical Market: Canada
The Pharmaceutical Market: China
The Pharmaceutical Market: Mexico
The 2009 Economic and Product Market Databook for Santiago de Cuba, Cuba
The Pharmaceutical Market: New Zealand
The Pharmaceutical Market: Greece
The Pharmaceutical Market: Switzerland
The Pharmaceutical Market: Brazil
The Pharmaceutical Market: Belgium
|
|
|
|
